22nd Century Group

22nd Century Group Empowering plants for a healthier future. Nasdaq: XXII 22nd Century Group, Inc.

(Nasdaq: XXII) is a next-generation plant biotechnology company, focused on improving human health through plant science. Using our breakthrough, patent-protected IP to control nicotine biosynthesis in the tobacco plant, we have developed the first market-ready, reduced nicotine content (RNC) tobacco plants and cigarettes containing 95% less nicotine. We received the first and only FDA MRTP author

ization for a combustible cigarette in December 2021. The sole function of our cigarettes is to make it easier to reduce the number of cigarettes smoked. In tobacco, hemp/cannabis, and hop plants, 22nd Century employs a unique and innovative platform of modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding, to deliver healthier solutions for pressing issues. We create new, proprietary plants with select alkaloid, terpenoid, and flavonoid profiles, improved yields, and valuable agronomic traits for the life science and consumer products industries.

Address

500 Seneca Street Ste 507
Buffalo, NY
14204

Website

Alerts

Be the first to know and let us send you an email when 22nd Century Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to 22nd Century Group:

Shortcuts

Share

Category